— Know what they know.
Not Investment Advice
Also trades as: MLECW (NASDAQ) · $vol 0M

MLEC NASDAQ

Moolec Science S.A.
1W: -15.2% 1M: -30.2% 3M: -38.4% YTD: +14.7% 1Y: -66.0% 3Y: -98.9% 5Y: -99.7%
$4.75
-0.06 (-1.25%)
 
Weekly Expected Move ±13.7%
$3 $4 $5 $5 $6
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 23 · $3.4M mcap · 517027 float · 3.63% daily turnover · Short 42% of daily vol

Revenue Segmentation

By Geography

Income Trends

Revenue
$6M +521.5% ▲
Gross Profit
$473K +429.8% ▲
Operating Income
-$9M -35.9% ▼
Net Income
-$7M +85.9% ▲
EPS (Diluted)
$-0.19 +87.3% ▲
EBITDA
-$6M +88.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023
Revenue$0$0$905K$6M
YoY Growth+0.0%+0.0%+0.0%+521.5%
Cost of Revenue$0$0$1M$5M
Gross Profit$0$0-$143K$473K
Gross Margin——-15.8%8.4%
R&D Expenses$0$985K$1M$2M
SG&A Expenses$14K$3M$48M$7M
Operating Expenses$14K$4M$7M$10M
Operating Income-$14K-$2M-$7M-$9M
Operating Margin——-735.2%-160.8%
Interest Expense$0$2K$160K$1M
Income Before Tax-$14K-$94K-$52M-$8M
Tax Expense$0$0-$235K-$1M
Net Income-$14K-$5M-$52M-$7M
Net Margin——-5722.2%-130.0%
EPS (Diluted)$-0.00$-0.12$-1.50$-0.19
EBITDA-$14K-$4M-$52M-$6M
Shares Outstanding17M38M34M38M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms